CROSS-TALK BETWEEN NEUROMELANIN AND SYNUCLEIN IN PARKINSON’S DISEASE

CROSS-TALK BETWEEN NEUROMELANIN AND SYNUCLEIN IN PARKINSON’S DISEASE

Bibliographic Details
Main Authors:	Marta García-Gómara, Ana Garcia-Osta, Mar Cuadrado-Tejedor
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123008461

Similar Items

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
by: Shengli Xu, et al.
Published: (2015-06-01)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson’s Disease
by: Ioannis Ugo Isaias, et al.
Published: (2016-08-01)

Nigrosome and neuromelanin imaging as tools to differentiate parkinson's disease and parkinsonism
by: Deblina Biswas, et al.
Published: (2022-01-01)

An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
by: Qiang Liu, et al.
Published: (2023-08-01)

Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease
by: Dhairya A. Lakhani, et al.
Published: (2024-01-01)

Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
by: Iria Carballo-Carbajal, et al.
Published: (2019-03-01)

Current animal models of Alzheimer´s disease: challenges in translational research
by: Mar eCuadrado-Tejedor, et al.
Published: (2014-09-01)

PENCIL imaging: A novel approach for neuromelanin sensitive MRI in Parkinson's disease
by: Peng Liu, et al.
Published: (2024-05-01)

Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
by: Dafna Ben Bashat, et al.
Published: (2022-10-01)

Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson’s disease
by: Bart de Laat, et al.
Published: (2024-02-01)

Melanin and Neuromelanin Fluorescence Studies Focusing on Parkinson’s Disease and Its Inherent Risk for Melanoma
by: Dieter Leupold, et al.
Published: (2019-06-01)

Predictive markers for Parkinson's disease using deep neural nets on neuromelanin sensitive MRI
by: Sumeet Shinde, et al.
Published: (2019-01-01)

Disease Duration Influences Gene Expression in Neuromelanin-Positive Cells From Parkinson’s Disease Patients
by: Katarína Tiklová, et al.
Published: (2021-11-01)

Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson’s disease and controls
by: Amée F. Wolters, et al.
Published: (2023-01-01)

Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson’s disease with freezing of gait
by: Shangpei Wang, et al.
Published: (2023-02-01)

Quantitative iron–neuromelanin MRI associates with motor severity in Parkinson's disease and matches radiological disease classification
by: Septian Hartono, et al.
Published: (2023-11-01)

PLA2G4E AS AN ESSENTIAL PROTEIN FOR PROPER SYNAPTIC FUNCTION AND BRAIN DEVELOPMENT
by: Sara Badesso, et al.
Published: (2023-10-01)

The immune system: uncharted pathways between senses and the brain
by: Noelia Casares, et al.
Published: (2024-01-01)

Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease
by: Martín Martínez, et al.
Published: (2023-04-01)

Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
by: Frédérique Depierreux, et al.
Published: (2021-07-01)

Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson’s disease and essential tremor
by: Xinhui Wang, et al.
Published: (2023-01-01)

Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach
by: Mojtaba Jokar, et al.
Published: (2023-02-01)

Fronto-striato-thalamic circuit connectivity and neuromelanin in schizophrenia: an fMRI and neuromelanin-MRI study
by: Sunah Choi, et al.
Published: (2023-11-01)

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
by: Mónica Gómez-Benito, et al.
Published: (2020-04-01)

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease
by: Mar Cuadrado-Tejedor, et al.
Published: (2019-06-01)

Epigenetic drugs in Alzheimer’s disease
by: Cuadrado-Tejedor Mar, et al.
Published: (2013-10-01)

Contrast mechanisms associated with neuromelanin-MRI.
by: Trujillo, P, et al.
Published: (2016)

Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain
by: Manning-Boğ Amy B, et al.
Published: (2011-01-01)

The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration
by: Alexandra Moreno-García, et al.
Published: (2021-01-01)

Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
by: Tapan Behl, et al.
Published: (2021-01-01)

NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural network
by: Rahul Gaurav, et al.
Published: (2022-01-01)

Alpha-Synuclein spreading in Parkinson disease
by: Ariadna eRecasens, et al.
Published: (2014-12-01)

Alpha-Synuclein Aggregation in Parkinson's Disease
by: E. Srinivasan, et al.
Published: (2021-10-01)

The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies
by: Maximilian Wulf, et al.
Published: (2022-11-01)

Neuromelanin is an immune stimulator for dendritic cells <it>in vitro</it>
by: Oberländer Uwe, et al.
Published: (2011-11-01)

GALECTIN-3 SHAPES TOXIC ALPHA-SYNUCLEIN AGGREGATES IN PARKINSON´S DISEASE
by: Juan Garcia-Revilla, et al.
Published: (2023-10-01)

Diagnostic performance of a high-spatial-resolution voxelwise analysis of neuromelanin-sensitive imaging in early-stage idiopathic Parkinson’s disease
by: Minjung Seong, et al.
Published: (2023-05-01)

Nuclear Alpha-Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
by: María E. Jimenez-Capdeville, et al.
Published: (2025-01-01)

Cross-talk between traditional Chinese medicine and Parkinson's disease based on cell autophagy
by: Mufei Wang, et al.
Published: (2023-06-01)

α-Synuclein and dopamine at the crossroads of Parkinson's disease.
by: Venda, L, et al.
Published: (2010)